Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics
- PMID: 11751511
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics
Abstract
PURPOSE/EXPERIMENTAL DESIGN: The importance of detection of disseminated isolated tumor cells (ITCs) in bone marrow (BM) is still not settled. BM aspirates from 920 patients with primary breast cancer were analyzed for tumor cells by standardized direct immunocytochemical analysis (ICC) of 2 x 10(6) mononuclear cells (MNCs) using anticytokeratin monoclonal antibody (AE1/AE3). Samples (637) were analyzed by negative immunomagnetic enrichment (IMS) followed by ICC (10 x 10(6) MNCs). Analyses of the primary tumor specimens have been performed, including histomorphology, tumor-node-metastasis (TNM) staging, grading, and immunohistochemical analyses.
Results: Of the patients with infiltrating carcinoma, 63% were node negative (N0) and 33%, node positive (N+). The results show the presence of tumor cells in 13.4% of the evaluable patients after direct ICC analysis. The presence of tumor cells correlated to the nodal- and tumor stage, showing BM positivity in 9.9% of the N0 cases and 20.6% in the N+ group (P < 0.0005), 11.2% of the stage T(1) were positive, and 15.0% and 22.6% were positive in the T(2) and T(3/4) groups, respectively (P = 0.013). No correlation between detection of ITC and detection of p53 and cathepsin D expression was found. Vascular invasion and c-erbB2 expression were associated with ITCs in BM (P = 0.045 and P = 0.024, respectively). Node-negative patients with estrogen receptor (ER)+ and/or progesterone receptor (PgR)+ tumors had lower frequency of ITCs than ER-/PgR- (P = 0.004). The use of negative IMS increased the frequency of positive BM by 63% (P < 0.0005).
Conclusions: The direct ICC detection of ITCs in BM correlated with primary tumor stage, nodal stage, vascular invasion, c-erbB2 expression, and ER/PgR status. Analysis of larger BM samples by negative IMS resulted in increased number of ITC-positive patients.
Similar articles
-
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.J Clin Oncol. 2003 Sep 15;21(18):3469-78. doi: 10.1200/JCO.2003.02.009. J Clin Oncol. 2003. PMID: 12972522
-
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.Clin Cancer Res. 2004 Aug 15;10(16):5342-8. doi: 10.1158/1078-0432.CCR-04-0245. Clin Cancer Res. 2004. PMID: 15328170
-
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.Cancer. 2005 Mar 1;103(5):884-91. doi: 10.1002/cncr.20834. Cancer. 2005. PMID: 15666325
-
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed.Cytotherapy. 2003;5(1):40-5. doi: 10.1080/14653240310000065. Cytotherapy. 2003. PMID: 12745581
-
Cytomorphological evaluation of non-haematopoietic malignancies metastasizing to the bone marrow.Am J Blood Res. 2023 Feb 15;13(1):1-11. eCollection 2023. Am J Blood Res. 2023. PMID: 36937461 Free PMC article. Review.
Cited by
-
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.Breast Cancer Res. 2012 Aug 14;14(4):R117. doi: 10.1186/bcr3242. Breast Cancer Res. 2012. PMID: 22889108 Free PMC article.
-
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.Clin Exp Metastasis. 2005;22(1):39-46. doi: 10.1007/s10585-005-3222-y. Clin Exp Metastasis. 2005. PMID: 16132577
-
Inhibition of osteolytic bone metastasis by unfractionated heparin.Clin Exp Metastasis. 2008;25(8):903-11. doi: 10.1007/s10585-008-9212-0. Epub 2008 Sep 24. Clin Exp Metastasis. 2008. PMID: 18814041
-
Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.BMC Cancer. 2011 Jun 16;11:252. doi: 10.1186/1471-2407-11-252. BMC Cancer. 2011. PMID: 21679400 Free PMC article. Clinical Trial.
-
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.NPJ Breast Cancer. 2021 Sep 6;7(1):113. doi: 10.1038/s41523-021-00323-8. NPJ Breast Cancer. 2021. PMID: 34489453 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous